Matches in Wikidata for { <http://www.wikidata.org/entity/Q99545576> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q99545576 description "article scientifique publié en 2020" @default.
- Q99545576 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99545576 description "scientific article published on 15 September 2020" @default.
- Q99545576 description "wetenschappelijk artikel" @default.
- Q99545576 description "наукова стаття, опублікована 15 вересня 2020" @default.
- Q99545576 name "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 name "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 type Item @default.
- Q99545576 label "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 label "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 prefLabel "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 prefLabel "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 P1433 Q99545576-E4907B11-EE87-435D-B212-7B942ED4B2F0 @default.
- Q99545576 P1476 Q99545576-A4C3EB70-6074-4481-9CA5-160E8B2D08C1 @default.
- Q99545576 P2093 Q99545576-14A7C44D-1FFD-442E-9DD5-12BCD77CDEE4 @default.
- Q99545576 P2093 Q99545576-688316AC-88D6-434C-BCBF-79739CB6983E @default.
- Q99545576 P2093 Q99545576-8C3B8B90-F9DE-4926-9D51-64405851E801 @default.
- Q99545576 P2093 Q99545576-939E368B-A72E-4204-94B3-216A1934FEC1 @default.
- Q99545576 P2093 Q99545576-9E3AE1B6-2CBE-49C5-9F84-FAC60343F859 @default.
- Q99545576 P2093 Q99545576-9F5CED09-91BA-4D3D-91E1-E98D12112721 @default.
- Q99545576 P2093 Q99545576-A77F5D0B-1A38-4D18-8057-85996CB05B21 @default.
- Q99545576 P2093 Q99545576-BA12CBD1-34B9-4888-9DAE-2A13EFA04520 @default.
- Q99545576 P2093 Q99545576-C8CE3386-E38D-447A-863D-9761478EC930 @default.
- Q99545576 P31 Q99545576-78D50D14-00EC-4E37-B4FC-AAFECDBEC33C @default.
- Q99545576 P356 Q99545576-73E182A2-731D-46B2-902A-F3A256A35C0E @default.
- Q99545576 P50 Q99545576-ACA050C8-2782-4391-9B5C-D019F4BB663D @default.
- Q99545576 P577 Q99545576-69E432FF-61DF-4D1E-8D17-B30662BEEF2E @default.
- Q99545576 P698 Q99545576-8909FB44-1656-441C-859A-E96711704339 @default.
- Q99545576 P921 Q99545576-002C53AC-64AB-454C-BD70-7905E4337E4A @default.
- Q99545576 P921 Q99545576-FB45C2E7-D17C-497C-8CE9-C4CBBB2059BC @default.
- Q99545576 P932 Q99545576-A5F9671E-EDED-47FA-9B9A-37871A8462D5 @default.
- Q99545576 P356 S00508-020-01735-5 @default.
- Q99545576 P698 32930860 @default.
- Q99545576 P1433 Q15759796 @default.
- Q99545576 P1476 "Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease" @default.
- Q99545576 P2093 "Emina Halilbasic" @default.
- Q99545576 P2093 "Günter Fauler" @default.
- Q99545576 P2093 "Harald Hofer" @default.
- Q99545576 P2093 "Karl Kashofer" @default.
- Q99545576 P2093 "Martin Krssak" @default.
- Q99545576 P2093 "Michael Wolzt" @default.
- Q99545576 P2093 "Petra Munda" @default.
- Q99545576 P2093 "Stefan Traussnigg" @default.
- Q99545576 P2093 "Tatjana Stojakovic" @default.
- Q99545576 P31 Q13442814 @default.
- Q99545576 P356 "10.1007/S00508-020-01735-5" @default.
- Q99545576 P50 Q62560551 @default.
- Q99545576 P577 "2020-09-15T00:00:00Z" @default.
- Q99545576 P698 "32930860" @default.
- Q99545576 P921 Q1546498 @default.
- Q99545576 P921 Q66299798 @default.
- Q99545576 P932 "8116226" @default.